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Abstract
Background: Early infant feeding with intact or extensively hydrolyzed (EH) proteins or free amino acids (AA) may
differentially affect intestinal microbiota composition and immune reactivity. This multicenter, double-blind,
controlled, parallel-group, pilot study compared stool microbiota from Baseline (1–7 days of age) up to 60 days of
age in healthy term infants who received mother’s own milk (assigned to human milk [HM] reference group) (n =
25) or were randomized to receive one of two infant formulas: AA-based (AAF; n = 25) or EH cow’s milk protein
(EHF; n = 28). Stool samples were collected (Baseline, Day 30, Day 60) and 16S rRNA genes were sequenced. Alpha
(Shannon, Simpson, Chao1) and beta diversity (Bray Curtis) were analyzed. Relative taxonomic enrichment and fold
changes were analyzed (Wilcoxon, DESEq2). Short/branched chain fatty acids (S/BCFA) were quantified by gas
chromatography. Mean S/BCFA and pH were analyzed (repeated measures ANOVA).
Results: At baseline, alpha diversity measures were similar among all groups; however, both study formula groups
were significantly higher versus the HM group by Day 60. Significant group differences in beta diversity at Day 60
were also detected, and study formula groups were compositionally more similar compared to HM. The relative
abundance of Bifidobacterium increased over time and was significantly enriched at Day 60 in the HM group. In
contrast, a significant increase in members of Firmicutes for study formula groups were detected at Day 60 along
with butyrate-producing species in the EHF group. Stool pH was significantly higher in the AAF group at Days 30
and 60. Butyrate increased significantly from Baseline to Day 60 in the EHF group and was significantly higher in
study formula groups vs HM at Day 60. Propionate was also significantly higher for EHF and AAF at Day 30 and AAF
at Day 60 vs HM. Total and individual BCFA were higher for AAF and EHF groups vs HM through Day 60.
(Continued on next page)
© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: rhutkins1@unl.edu
7Department of Food Science and Technology, University of Nebraska, 258
Food Innovation Center, Lincoln, NE 68588-6205, USA
Full list of author information is available at the end of the article
Kok et al. BMC Microbiology          (2020) 20:337 
https://doi.org/10.1186/s12866-020-01991-5
(Continued from previous page)
Conclusions: Distinct patterns of early neonatal microbiome, pH, and microbial metabolites were demonstrated for
infants receiving mother’s own milk compared to AA-based or extensively hydrolyzed protein formula. Providing
different sources of dietary protein early in life may influence gut microbiota and metabolites.
Trial registration: ClinicalTrials.gov Identifier: NCT02500563. Registered July 28, 2015.
Keywords: Infant formula, Infant microbiota, Bifidobacterium, Short chain fatty acids
Background
Cow’s milk allergy (CMA) is one of the most common food
allergies affecting infants [1, 2]. Allergen exclusion, through
use of formulas based on extensively hydrolyzed (EH) pro-
teins, has traditionally been used to manage CMA. Amino
acid (AA)-based formulas have also become available and
may be used in more severe cases [3]. However, recent data
suggest that use of AA-based formulas may delay the acqui-
sition of immune tolerance [4], potentially due to the
complete absence of allergenic epitopes that are required to
induce oral tolerance through early exposure of intact dietary
proteins [5, 6]. Unlike AA-based formulas, the presence of
small peptide fragments in protein hydrolysates has been re-
lated to the stimulation of immune tolerance to cow’s milk
protein [7]. This is particularly relevant with the advent of a
new paradigm in the management of food allergy in infants
that involves stimulation of the development of immune tol-
erance to food antigens. Whereas hydrolyzed formulas can
minimize antigen contact, the mechanism of action also in-
cludes the induction of immune tolerance [8].
Oral tolerance development research has recently fo-
cused on the influence of host-microbe interactions on
immune function, specifically that the presence of cer-
tain intestinal microbes could promote tolerance to diet-
ary antigens [9–11]. For example, consumption of
Lactobacilllus rhamnosus GG (in EH formula) by infants
with CMA was reported to stimulate immune tolerance
[4, 12, 13]. One hypothesized mechanism of enhanced
immune tolerance is enrichment of butyrate-producing
bacteria, with butyrate stimulating the development of
regulatory T (Treg) cells. As known mediators of oral tol-
erance [14–17], Treg cells have a demonstrated protect-
ive role, and a reduction could lead to an allergic
phenotype [18, 19]. Ruohtula and colleagues demon-
strated that an increase in highly activated Treg cells was
associated with colonization of butyrate-producing bac-
teria and suggested a very narrow window of opportun-
ity (birth up to 3 months of age) for the primary
prevention of atopic diseases [20]. Given the potential of
protein hydrolysates to induce oral tolerance, we hy-
pothesized that EH-based formulas encourage the pro-
duction of butyrate through the enrichment of butyrate-
producing microbes. Therefore, the primary goals of this
study were to assess the effects of EH and AA-based for-
mulas on the intestinal microbial composition of infants
and the subsequent shift in formation of short and
branched chain fatty acids. Preliminary findings were
previously reported at the Nutrition 2019 - American
Society of Nutrition annual conference [21, 22].
Results
Participants
A total of 78 participants were enrolled and assigned to a
study group (EHF: n= 28; AAF: n= 25; HM: n = 25) (Fig. 1).
Participants who were randomized but consumed no study
formula (EHF: n= 2; AAF: n= 1) were not included in subse-
quent analyses. No differences in body weight, length, or
head circumference were observed between groups at study
enrollment (Table 1); sex, race and ethnic distribution were
similar among groups (Additional File 1: Table S1). Statisti-
cally significant differences were detected at Day 30 in weight
and length for the EHF vs HM group and at Day 60 in
weight for the EHF and AAF vs HM groups. No differences
in head circumference were detected at any study time point.
No group differences in study formula intake (mean ± SE; fl
oz./day) were detected between study formula groups at Day
30 (EHF: 27.8 ± 1.4 vs AAF: 25.8 ± 1.5: P= 0.355) or Day 60
(EHF: 33.4 ± 2.0 vs AAF: 28.7 ± 2.2: P= 0.128). No statisti-
cally significant group differences were detected for study
discontinuation (EHF: n= 8, 31%; AAF: n= 10, 42%; HM:
n= 8, 32%; P= 0.685) or discontinuation related to study for-
mula (EHF: n= 4, 15%; AAF: n= 3, 13%). In the total study
population, two participants discontinued due to formula in-
tolerance as determined by the study investigator (EHF: n=
1; AAF: n= 1). Parental decision was the most common rea-
son for discontinuation unrelated to study formula (5 partici-
pants). A total of four participants experienced serious
adverse events and were categorized within the following
body systems: Gastrointestinal (HM, n= 1), Respiratory
(EHF, n= 1; AAF, n= 1; HM, n= 1), or Urogenital (EHF,
n= 1). Participants who completed the study (EHF: n= 18;
AAF: n= 14; HM: n= 17) provided stool data at all study
time points and were included in subsequent analyses.
Alpha and beta diversity
To compare overall changes in taxonomic profiles within
and between each feeding group, alpha and beta diver-
sity measures were calculated. Alpha diversity remained
relatively stable from Baseline to Day 30 and from Base-
line to Day 60 for the HM group when measured using
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Fig. 1 Timeline and participant flow diagram. a Timeline for the entire study duration. Fecal samples were collected based on specified days
(infant’s age) as stated for each visit. Baseline samples were collected after meconium. b Flow chart describing subject exclusion and
participation. Subjects who did not provide a sample or did not complete all 3 visits were excluded from the final analysis
Table 1 Achieved weight, length, and head circumferencea
Age (Days) Group (n) Weight (g) Length (cm) Head circumference (cm)
1–7 (Baseline) AAF (24) 3294 ± 77 50.8 ± 0.04 34.3 ± 0.2
EHF (26) 3296 ± 74 50.4 ± 0.04 34.9 ± 0.2
HM (25) 3243 ± 76 50.9 ± 0.04 34.9 ± 0.2
30 AAF (16) 4073 ± 112 53.8 ± 0.05 37.2 ± 0.3
EHF (20) 3912 ± 100b 52.8 ± 0.05b 36.9 ± 0.2
HM (20) 4345 ± 100 54.8 ± 0.05 37.7 ± 0.2
60 AAF (15) 4939 ± 127b 57.0 ± 0.05 39.1 ± 0.3
EHF (18) 4781 ± 118b 57.1 ± 0.05 38.9 ± 0.2
HM (19) 5295 ± 114 58.2 ± 0.05 39.5 ± 0.2
a Mean ± standard error (SE)
b Significantly lower than HM, P < 0.05, two-tailed test
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Shannon and Simpson indices; whereas Chao1 richness
significantly increased from Baseline to Day 60 (Fig. 2a).
In contrast, alpha diversity increased over time in the
AAF and EHF groups and was significantly higher for
each compared to the HM group at Day 60 by all mea-
sures. Significant differences were also detected between
Day 30 and Day 60 for the EHF (all measures) and AAF
groups (Shannon index only). To assess community dif-
ferences in beta diversity, PCoA plots were constructed
using Bray-Curtis distance matrix (Fig. 2b). Overall com-
munity differences were detected (PERMANOVA, P =
0.001) with AAF and EHF communities displaying
higher similarities at Day 60, compared to the HM
group.
Compositional change of genus level relative abundance
between baseline and days 30 and 60
Differences in taxonomic relative abundance between
Baseline and Day 30 and between Baseline and Day 60
were evaluated using Wilcoxon tests and visualized for
each group by heat tree mapping. For all 3 groups, sig-
nificant taxonomic changes began to appear by Day 30
(Fig. 3). In the AAF and EHF groups, members of Firmi-
cutes (e.g. Lachnospiraceae) were already significantly
Fig. 2 Alpha and beta diversity measurements of the infant microbiome across feeding groups. a Pairwise comparisons of alpha diversity indices
(Shannon, Simpson, Chao1) were carried out between visits to examine specific comparisons of interest in each feeding group; amino acid (AAF;
red), extensively hydrolyzed formula (EHF; green) and human milk (HM; blue). Boxplots show the median, first and third quartiles and the whiskers
extend out to the 1.5 x IQR (Interquartile Range) of the upper and lower limit. * indicates significant difference between a pairwise comparison of
group-visit combinations (FDR < 0.05). ‡ and † indicates that at baseline and day 60 respectively, the HM group was significantly different
compared to the AA and EHF groups (FDR < 0.05). ○ represents outliers. b Comparison of community profiles at the ASV level between feeding
groups at day 60. Principle coordinates analysis (PCoA) using Bray Curtis distance was carried out followed by PERMANOVA analysis (p = 0.001)
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higher at Day 30 (Fig. 3a,c). In the AAF group, there was
an observed increase in Lactobacillus and Enterococcus
and a decrease in Rothia at both Days 30 and 60 (Fig.
3a,b). At Day 60, an increase was observed in Akkermansia,
Actinomyces, Eggerthella, Peptoniphilus, [Ruminococcus], Blau-
tia, Dorea, Ruminococcus and [Eubacterium] together with a
decrease in Veilonella and Streptococcus. In the EHF group,
there was an observed increase in Enterococcus at both Days
30 and 60 (Fig. 3c,d). By Day 60, Eggerthella, Lactobacillus,
[Ruminococcus] and members of Clostridiaceae and Rumino-
coccaceae were significantly higher while Escherichia, Bacter-
oides and Streptococcus had significantly decreased. For the
HM group (Fig. 3e,f), members of Actinobacteria were signifi-
cantly higher at Day 30. By Day 60, a significant increase in
Bifidobacterium and Lactobacillus and a significant decrease
in Staphylococcus were observed.
To further evaluate the differential abundance of specific
Amplicon Sequence Variants (ASVs, unique DNA se-
quence from a marker gene) from Baseline and Day 60,
the DESeq2: differential gene expression analysis based on
the negative binomial distribution package in R was used
to compute log 2-fold changes (log2FC) of ASVs. Similar
results were observed as before. In the AAF (Fig. 4a) and
EHF (Fig. 4b) groups, a significant shift in members of Fir-
micutes were observed. This included an increase in En-
terococcus and Blautia species and species belonging to
the Clostridia IV and XIVa clusters, such as Ruminococ-
cus, Dorea, Eubacterium, Roseburia, Faecalibacterium,
and Coprococcus. A significant decrease in species of
Staphylococcus, Streptococcus, Veillonella, in addition to
other decreases in Bacteroides and Rothia, were also ob-
served. In the HM group (Fig. 4c), overall shifts in
Fig. 3 Heat trees comparing the relative abundances of taxa between a, c, e baseline and day 30 and b, d, f baseline and day 60 in the a. b
amino acid (AAF), c, d extensively hydrolysed formula (EHF) and e,f human milk (HM) groups. Taxa in orange are enriched at day 30 or day 60
while taxa in purple are enriched at baseline. Size of nodes correspond to the number of genera and color intensity corresponds to proportions.
Taxonomic log2 fold change is calculated using median proportions. Only taxa that were significantly different between visits, as determined
through Wilcoxon signed rank test (FDR < 0.05) are shown. Taxonomic tree in g acts as a reference and represents all genera present in
the samples
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members of Firmicutes were less apparent. However, a
significant increase in Dialister and Finegoldia, which was
not observed in the formula-fed groups occurred in the
HM group.
When organisms associated with butyrate production
were assessed, two different Roseburia ASVs (log2FC of
1.2 and 3.9), and a Faecalibacterium prausnitzii ASV
(log2FC of 3.9) increased in the EHF group. Roseburia and
Faecalibacterium were both predictors in the random for-
est variable importance plots for the EHF group (Add-
itional File 1: Fig. S1b). In comparison, a Roseburia ASV
and a Faecalibacterium prausnitzii ASV increased in the
AAF (log2FC of and 1.6 and 1.8 respectively) group. A sig-
nificant enrichment of Akkermansia (log2FC of 3.06) was
observed in the AAF group (similarly observed by Wil-
coxon test and random forest analysis) (Fig. 3a, 4a, Add-
itional File 1: Fig. S1a). Changes in different bifidobacteria
species occurred in each group. A Bifidobacterium longum
ASV was enriched in the HM group (log2FC of 2) but de-
creased in the AAF (log2FC of − 2.7) and EHF (log2FC of
− 1.6) groups. Bifidobacterium pseudocatenulatum corre-
sponded to a single ASV enriched in the AAF group
(log2FC of 1.2) and the two most enriched Bifidobacter-
ium ASVs in the EHF group (log2FC of 2.4 and 2.7). Ran-
dom forest analysis also demonstrated that
Bifidobacterium ASVs were the main predictors reflecting
whole microbiome changes between Baseline and Day 60
for the EHF and HM groups (Additional File 1: Fig. S1).
Group differences in genus level relative abundance at
day 60
Relative abundance between study groups at Day 60 was
also analyzed by a pairwise Wilcoxon comparison (Fig. 5).
Bifidobacterium was significantly higher and Firmicutes
significantly lower for the HM group compared to AAF
(Fig. 5a) and EHF (Fig. 5c) groups. Enterobacteriaceae,
Rothia and Clostridium were significantly higher and
Akkermansia and Peptoniphilus were significantly lower
for the EHF compared to the AAF group (Fig. 5b).
pH and S/BCFA
Stool pH values (mean ± SE) were similar among groups
at Baseline with no significant changes for EHF and HM
through Day 60. However, compared to EHF and HM,
mean pH values in the AAF group were significantly
higher at Days 30 (P < 0.01 for both) and 60 (P < 0.01 for
both) (Fig. 6a). With the exception of propionate (HM
significantly lower vs EHF group), no significant group
differences in S/BCFA (μmol/g; mean ± SE) were de-
tected at Baseline. Butyrate increased significantly from
Baseline to Day 60 in the EHF group (P = 0.026) and was
significantly higher vs HM at Days 30 and 60 (P < 0.01)
(Fig. 6c). Butyrate was also significantly higher for AAF
vs HM at Day 60 (P = 0.038). In the AAF group, propi-
onate levels significantly increased from Baseline to Day
30 (P < 0.01) and from Baseline to Day 60 (P = 0.026)
and was also significantly higher compared to the HM
group at Days 30 (P < 0.01) and 60 (P = 0.01) (Fig. 6d).
Total SCFA was similar for all groups through Day 30
but was significantly higher in the AAF versus HM
group at Day 60 (P = 0.04) (Fig. 6e). Both the AAF and
EHF groups displayed similar trends of total BCFA pro-
duction and were significantly higher compared to HM
at Day 30 (P < 0.01, P = 0.015 respectively) and Day 60
(P < 0.01 for both) (Fig. 6f, Additional File 1: Fig. S2).
Spearman correlations were calculated to associate taxa
Fig. 4 DESeq2 analysis of differentially abundant ASVs between baseline and day 60 for each feeding group; the a amino acid (AAF), b
extensively hydrolysed formula (EHF) and c human milk (HM) groups. Shrinkage estimations of log2 fold change values for each ASV were
computed and each point represents an ASV that was significantly different (FDR < 0.05). Each color represents a phylum; Actinobacteria (red),
Bacteroidetes (grey), Firmicutes (yellow), Proteobacteria (blue) and Verrucomicrobia (green)
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at the genus level with individual metabolites (Fig. S3).
Notable correlations include positive correlations be-
tween acetate and Bifidobacterium and between butyrate
and members of the Clostridia IV and XIVa clusters
(Roseburia, Faecalibacterium, Dorea, Coprococcus, Clos-
tridium and [Ruminococcus]). Butyrate was also posi-
tively correlated with Leuconostoc, Pseudoramibacter_
Eubacterium, Enteroccocus, Eggerthella, Blautia, Akker-
mansia, [Eubacterium] and Citrobacter.
Discussion
One of the most important factors affecting the develop-
ment and composition of the infant gut microbiome is
nutrition, specifically, the type of infant feeding [23–25].
In particular, human milk and infant formulas have been
previously demonstrated to induce differences in micro-
biota composition [26, 27]. In the current study, two
hypoallergenic infant formulas that had different sources
of protein were compared to human milk in infants from
birth to Day 60. These formulas have been previously or
are currently marketed, and have been demonstrated to
adequately support typical growth and safety [28]. In this
study, group differences in achieved growth between
study formula groups and the HM reference group were
detected, as could be expected. Weight gain in healthy
breastfed infants has been reported as typically faster
compared to those receiving formula feeding in the first
few months of life, but slower over for the remainder of
infancy [29].
The major groups of bacteria detected among all study
groups and time points belonged to phyla known to be
associated with the infant gut microbiome, including Fir-
micutes, Actinobacteria, Proteobacteria and Bacteroi-
detes [30, 31]. In particular, enrichment of
Bifidobacteriaceae in the HM reference group was con-
sistent with previous gut microbiome characteristics of
Fig. 5 Differential heat trees based on pairwise comparisons of taxonomic relative abundance between feeding groups at day 60; a human milk
(HM; yellow) vs amino acid (AA; purple), b extensively hydrolyzed formula (EHF; yellow) vs amino acid (AAF; purple) and c human milk (HM;
yellow) vs extensively hydrolyzed formula (EHF; purple). Taxonomic tree in d acts as a reference and represents all genera present in the day 60
samples. Taxonomic log2 fold change is calculated using median proportions. All colored taxa are significantly different between feeding groups
(Wilcoxon rank sum test; FDR p < 0.05). Size of nodes correspond to the number of genera and color intensity corresponds to proportions
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infants receiving mother’s own milk [13, 32]. In general,
Bifidobacterium spp. typically dominate the infant gut
early in life [33] especially B. bifidum, B. breve and B.
longum, but slowly attenuate during adolescence and
adulthood [34, 35]. Human milk serves as an initial source
of Bifidobacterium [36, 37] and, importantly, also provides
a continuing source of human milk oligosaccharides
(HMOs) throughout lactation. HMOs are specifically me-
tabolized by groups of bifidobacteria, B. longum in par-
ticular [38–41].
Abundance of bifidobacteria in the infant gut has been
suggested as protective against development of allergic
diseases [20, 42–46], and may be an advantage associated
with breastfeeding [47]. We observed that abundance of a
B. longum ASV increased in the HM reference group but
decreased in both study formula groups. In contrast, a sig-
nificant increase in B. pseudocatenulatum was demon-
strated in both study formula groups, particularly the EHF
group. The presence of B. pseudocatenulatum has previ-
ously been observed in both breastfed infants and those
receiving infant formula [48, 49], although the role of this
species in the development of immune or other health pa-
rameters is unclear [48, 50].
In the current study, the trend toward higher alpha di-
versity was similar for infants receiving EHF or AA-
based formulas, suggesting the compositional evenness
and richness of taxa in the infant gut was influenced by
feeding during early life. Similarly, stool microbiota
Fig. 6 pH and S/BCFA analysis of stool samples. For the different feeding groups; amino acid (AAF; red), extensively hydrolyzed formula (EHF;
green) and human milk (HM; blue), a pH, b acetate, c butyrate, d propionate, e total SCFA and f total BCFA were measured at each visit. A
repeated measure analysis of variance (ANOVA) using a Toeplitz covariance structure was used with Bonferroni’s post-hoc test. Each point
represents the mean and error bars represent upper and lower limits at a 95% confidence interval. * represents significant difference between
visits for AAF in a pH and d propionate and EHF in c butyrate (p < 0.05). Points that do not share the same letter(s) at a given visit are
significantly different from each other (p < 0.05)
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diversity has been demonstrated to be significantly
higher in infants receiving formula vs human milk in US
[51] and Korean populations [52]. In the US study, lower
diversity in infants receiving human milk was likely due
to the dominance of Bifidobacterium, which are enriched
by HMOs [35, 38, 53]. In the current study, diversity
within the HM group was stable through Days 30 and
60 (albeit an increase in Chao1 richness at Day 60),
reflecting minimum change in gut community compos-
ition throughout the study period. The increase in
Chao1 richness was likely influenced by an increase in
the number of rare species. In contrast, the increased di-
versity over time for infants receiving EH or AA-based
formulas was associated with enrichment of members of
the phylum Firmicutes.
Whereas beta diversity measures demonstrated a lack of
defined separation between groups, the overlap between the
AAF and EHF groups at Day 60 further suggested greater
similarity in community composition compared to the HM
reference group. Nevertheless, the association between diver-
sity and health remains undefined, partly because diversity is
not reflective of ecosystem function and stability [54, 55]. In-
stead, the underlying ecological mechanisms driven by func-
tionally conserved species should be considered in addition
to community diversity. Although the gut microbiome is
more diverse in infants receiving formula compared to hu-
man milk, the association between atopy and microbial di-
versity in the infant gut (as assessed across several studies)
remains inconclusive [56–60]. For example, children with
food sensitization in early life had lower alpha diversity com-
pared with children without these conditions [61].
Downstream taxonomic analyses yielded similar re-
sults, suggesting that different sources of dietary protein
may have been responsible for these changes in gut
community composition. These changes may further be
associated with the differential production of metabolites
such as S/BCFA, which are known to communicate with
the immune system [62].
The enrichment of Firmicutes in both study formula
groups was consistent with previous reports and
reflected a more adult-like microbiome [52, 63, 64]. The
phylum Firmicutes includes commensal Clostridia spe-
cies and related taxa known to produce butyrate and in-
duce Treg cells in germ-free mice [16, 65]. Indeed, a
majority of the ASVs associated with butyrate produc-
tion identified in the formula groups belonged to Clos-
tridia IV and XIVa clusters (including Ruminococcus,
Dorea, Lachnospira, Eubacterium, Roseburia, Faecalibac-
terium and Coprococcus [66, 67]), potentially accounting
for the observed increase in butyrate in these groups.
This is supported by the positive correlations observed
between butyrate concentrations and these specific taxa.
Furthermore, ASVs corresponding to Faecalibacterium
and Roseburia identified in the EHF group (by both
DESeq2 differential abundance and random forest ana-
lysis) had as much as a log2 fold increase of 3.9. Butyrate
production through cross-feeding reactions between the
observed bifidobacteria and butyrate-producing organ-
isms (similar to species demonstrated in the EHF group)
has also been demonstrated previously [68, 69]. Butyrate
is the main energy source for colonic epithelial cells and
was shown to regulate gut permeabilty [70]. Butyrate
producers Roseburia and F. prausnitzii are found in high
numbers in the gut of healthy adults [66, 71, 72] and F.
prausnitzii has been studied as a beneficial commensal
correlated with improved health in adults [71, 73]. Fae-
calibacterium was also found to be lower in abundance
in children belonging to two different birth cohorts who
had higher risks in the development of atopy [74] and in
children that developed allergic diseases [20]. Interest-
ingly, enrichment of A. muciniphila was only observed in
the AAF group with a significant fold increase from base-
line to Day 60 along with higher levels of propionate
throughout. A. muciniphila is pH sensitive, has optimum
growth in environments closer to neutral pH, and pro-
duces propionate as a metabolic end product of mucin
degradation [75]. Some of the described benefits of propi-
onate include the improvement of glucose metabolism in
adults [76, 77] and the prevention of allergic diseases in
children [78]. An association between longer uninter-
rupted sleep and an increase in propionate was also ob-
served in infants of the Baby-Led Introduction to SolidS
(BLISS) cohort [79].
Distinct patterns of pH and microbial metabolites were
also observed for infants receiving EH or AA-based for-
mulas compared to mother’s own milk. Although higher
stool pH has been previously observed in a small study
of infants receiving formula vs human milk [80], a dra-
matic shift over the past century in mean fecal pH values
among breastfed infants in developed countries (an in-
crease from 5.0 to 6.5) was recently reported [81]. The
researchers suggested that this shift was correlated with
the presence and absence of specific taxa; specifically, in-
creased pH values were associated with an increase in
dysbiosis-associated taxa (Clostridiaceae, Enterobacteria-
ceae, Peptostreptococcocaceae and Veillonellaceae) and a
decrease in Bifidobacteriaceae. In the results presented
here, the mean fecal pH of the AAF group at Days 30
and 60 was more than 1 pH unit higher than the range
reported in Henrick et al. [81] and significantly higher
compared to the EHF and HM reference groups. Similar
taxonomic shifts were also observed, including a signifi-
cant increase in Clostridiaceae and Enterobacteriaceae
and decrease in Bifidobacteriaceae in the AAF group
compared to the HM group. The role of these species in
amino acid fermentation and metabolism can potentially
influence the observed differences in pH [82, 83]. Add-
itionally, increased BCFA in the AAF and EHF groups
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was consistent with free branched-chain amino acid fer-
mentation in the colon [84, 85].
Although butyrate was higher for both study groups
compared to HM at Day 60, a significant increase from
baseline to Day 60 was evident only for the EHF group.
This finding, along with the presence of butyrate-
producing organisms in the EHF group, may provide in-
sights into the Treg-associated mechanisms by which an
EH formula more effectively accelerates oral tolerance
acquisition in children with CMA versus an AA-based
formula [4, 20, 86]. Previously, the role of FOXP3+ Treg
cells and its mechanisms in the development of oral tol-
erance have been described [86]. Other studies have
demonstrated the presence of higher frequencies of cir-
culating Treg cells in children who acquired spontaneous
tolerance [18] and in children who outgrew CMA [87].
Importantly, butyrate has been linked to Treg stimulation
by increasing acetylation of FOXP3 and improving ac-
cessibility of transcriptional regulators at the gene pro-
moter region and other enhancer elements [16]. The
association between butyrate-producing bacteria and
Treg cell maturation was also evident after the first year
of life in a birth-cohort of Estonian and Finnish children
[20]. In that study, highly activated Treg cells increased
and demonstrated a strong association with the
butyrate-producing bacteria, thus increasing diversity of
the intestinal microbiome. Furthermore, shotgun meta-
genomic sequencing of infant stool samples from the
Canadian Healthy Infant Longitudinal Development
(CHILD) cohort demonstrated that infants who devel-
oped allergic sensitization later on in life were deficient
in butyrate-producing genes since 3 months of age [58].
Early diet choices may influence childhood develop-
ment during the first 1000 days of life and beyond. To-
gether with previous reports, our study suggests that
using an EH formula may accelerate oral tolerance ac-
quisition by supporting a microbiome that is capable of
producing butyrate. The EH formula was associated with
lower pH, shifted the microbiota composition toward
butyrate production (e.g., Roseburia, F. prausnitzii), and
altered the SCFA profile (more butyrate vs propionate
and acetate) compared to an AA-based formula. Further
research is warranted in this area.
Conclusions
The gut microbiome plays a critical role in the regula-
tion of allergic immune responses. Several distinct pat-
terns of early neonatal microbiome, pH, and microbial
metabolites were demonstrated for infants receiving
mother’s own milk compared to amino acid-based or ex-
tensively hydrolyzed protein formulas. The abundance of
Bifidobacterium was higher in breastfed infants, and Fir-
micutes were dominant in both of the infant formula
groups. Shifts in specific bacteria species were associated
with production of metabolites, particularly butyrate,
that is known to communicate with the host immune
system. Within the group receiving an EH formula, spe-
cific taxonomic shifts included the enrichment of butyr-
ate producers, potentially linked to the induction of oral
tolerance to cow milk proteins. However, it is not clear if
these outcomes are mediated through changes in the
microbiome.
Results from this study suggest that formulas with dif-
ferent protein sources affect the microbiome differently,
possibly impacting development and functionality of the
immune response. Longitudinal studies that include both
microbiome measurements and observations of im-
munological effects are needed to fully understand the
mechanisms by which these infant formulas function. In
addition, use of whole shotgun metagenomic sequencing
to uncover species and microbial pathways that contrib-
ute towards the production of beneficial metabolites is
needed. Finally, although these findings using stool sam-
ples provide a basis for understanding the influence of
particular types of formula feeding on the infant colonic
microbiota, just as for other studies based on fecal sam-




Healthy, term infants (1 to 7 days of age) were recruited
at four clinical sites in the United States. Eligible infants
were singleton births at 37–42 weeks gestational age
(GA) with appropriate birth weight for GA (defined as
birth weight between and inclusive of 5th and 95th per-
centiles [88, 89]; and started either infant formula feed-
ing or mother’s own breast milk feeding within 24 h of
birth. Infants whose mothers had chosen not to breast-
feed were solely formula-fed at least 24 h prior to
randomization. Infants from mother who intended to
breastfeed exclusively received mother’s-own breast milk
from Day 1 (day of birth was considered Day 0) through
study registration. Exclusion criteria included: caesarean
delivery; birth mother who had Type 1 diabetes; history
of underlying disease or congenital malformation likely
to interfere with normal growth and development or
participant evaluation; evidence of feeding difficulties
(from breast or bottle) or history of formula intolerance;
and immunodeficiency; signs of acute infection or use of
antibiotics (including topical antibiotics in the diaper
area) at study randomization/registration; and planned
use of probiotics during the study period.
Study design
This study was designed to examine the impact of early
feeding of EH casein formula on intestinal microbiota
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composition. At the time of study inception, little data
existed on which to base a formal sample size calcula-
tion. However, microbiota differences had been demon-
strated in a study with two groups of 18 infants each
[50]. Therefore, 20 infants per group were targeted to
complete the study feeding period. In this double-blind,
randomized, controlled, parallel-designed, prospective
trial participants were enrolled between August 2015
and May 2017. Parents or legally authorized representa-
tive(s) provided written informed consent prior to en-
rollment. The research protocol and informed consent
forms observing the Declaration of Helsinki were ap-
proved by Schulman IRB. Participants receiving infant
formula were randomly assigned to receive one of two
study formulas (Mead Johnson Nutrition, Evansville,
IN): an amino acid-based infant formula (AAF; marketed
PurAmino) or an extensively hydrolyzed protein infant
formula (EHF; previously marketed Nutramigen®)
through 60 days of age. Neither study formula included
added Lactobacillus rhamnosus GG. Similarly to Yeiser
at al. ([90]), a computer-generated randomization sched-
ule was prepared and inserted into sealed envelopes that
were consecutively-numbered. The individual study for-
mulas were designated using one of two unique codes.
Study formulas assigned to each participant were deter-
mined after opening the next sequential envelope. The
codes were known only to the sponsor. Formulas were
provided directly to parents at each visit prior to com-
pletion of the study or to withdrawal.
Neither the sealed envelopes nor the product labels
permitted unblinding by the study site. In addition,
the personnel involved in monitoring the study were
blinded to product identification. Only in the event of
a medical emergency that required knowledge of the
study formula for managing the participant’s manage-
ment, could blinding be broken. In this study, there
were no instances where it was necessary to prema-
turely break the study code.
Participants exclusively receiving mother’s own
breast milk were registered and assigned to a human
milk (HM) reference group. Study visits occurred at
Baseline (1–7 days of age), 30 (±3) days and 60 (±3)
days of age. Anthropometric measures (body weight,
length, and head circumference) were recorded at all
study visits. Parents collected Baseline stool samples
after meconium passed and ≤ 24 h of participant study
enrollment. Day 30 and 60 stool samples were col-
lected ±24 h of the study visit and compliant samples
were stored onsite at − 20 °C. Study completion was
defined as participants who provided a protocol-
compliant stool sample at all three study time points.
(Stool sample compliance criteria: Additional File 1,
Table S2). Serious adverse events were collected
throughout the study.
pH and S/BCFA analysis
A standard pH meter (Orion Research Inc., Boston,
Mass., USA) with a micro combination electrode (Fisher
Scientific, Lenexa, Kansas) was used to measure pH of
diluted (1:10, deionized water) and homogenized stool
samples. Short chain fatty acids (SCFA; acetate, butyrate
and propionate) and branched chain fatty acids (BCFA;
isovalerate and isobutyrate) were measured using gas
chromatography as described previously [91] with slight
modifications. Briefly, diluted, homogenized stool sam-
ples (1:10; phosphate-buffered saline) were centrifuged
(8000×g × 5min); pellets were stored at − 20 °C (for sub-
sequent DNA extraction). Supernatant was collected
(0.4 ml), and diethyl ether extracts were prepared and
quantified by gas chromatography (Clarus 580; PerkinEl-
mer, Waltham, MA, USA) using a fused silica capillary
column (Nukol 30 m × 0.25 mm id × 0.25 μm film;
Sigma-Aldrich, St. Louis, MO, USA) and a flame
ionization detector. Quantification of S/BCFA was based
on calculating response factors relative to known con-
centrations of 2-ethyl butyric acid. Internal standards of
2-ethyl butyric were used during quantification to cor-
rect for any variability caused by loss of analyte.
DNA extraction, 16S rRNA community sequencing and
analysis
DNA from stool samples were extracted using phenol-
chloroform as described by [92] with the exception that
all incubation times were carried out for 30 min and
DNA was recovered with 100 μl of DNase-free water.
Amplicon sequencing was performed by Neogen Gene-
Seek Operations (Lincoln, NE). Briefly, 2x250bp paired-
end 16S rRNA regions of the DNA samples were
sequenced with an Illumina MiSeq sequencer. Primers
used were 515F (5′-GTGCCAGCMGCCGCGGTAA-3′)
and 806R (5′-GGACTACHVGGGTWTCTAAT-3′),
flanking the 515 and 806 region. Barcodes were attached
to the 806R primers. A total of 8,789,037 sequences were
obtained with a mean of 51,099 sequences per sample.
Sequence analysis was conducted using QIIME 2.0:
Quantitative Insights Into Microbial Ecology [93].
Paired-end raw sequences were de-multiplexed and
imported into QIIME. FastQC was used to check for per
sample sequence quality and DADA2 was used to re-
move chimeric sequences [94]. To retain high quality se-
quences, forward reads were truncated to 240 bp and
reverse reads were truncated to 200 bp. In total, 6,043,
211 sequences were de-replicated into unique amplicon
sequence variants (ASV) and a list of representative se-
quences with 619 features was created. Taxonomy was
successfully assigned to 557 features using the Green-
genes database with a pre-trained classifier based on
99% sequence identity. In the Greengenes database,
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square brackets around taxonomy indicate suggested but
not verified taxonomy by the database curators. Alpha
and beta diversity measures were computed using a sam-
ple depth of 9351 sequences. Species-level taxonomic in-
formation that could not be obtained from the
Greengenes database was further identified through
BLASTn against the NCBI Refseq database and the top
hits were used as an identifier.
Statistical analysis
Analyses on measured pH and S/BCFA were performed
using Statistical Analytical System (SAS) software ver.
9.4 (SAS Inst., Cary, NC, USA). Differences in pH and S/
BCFA production between each group-visit combination
were analysed with a repeated measure analysis of vari-
ance (ANOVA) using a Toeplitz covariance structure.
The differences between the least square means of fixed
effects were used to compare between group-visit com-
binations. To account for multiple comparisons, a Bon-
ferroni adjustment was used and p < 0.05 was considered
significant. In this model, ‘group’ and ‘visit’ were the
fixed effects while ‘visit’ was the repeated measure and
subject within group was used as the random error. Data
transformations were used to adjust for normality;
double square root transformation for acetate, butyrate
and total SCFAs and cubic transformation for propion-
ate and isovalerate. To adjust for the inflated number of
zeros observed (not detectable) in the measurement of
isobutyrate throughout the samples, an analysis of prob-
ability of a zero observation was carried out. Then, a
modified log transformation was used to adjust for nor-
mality after the removal of zeros from the dataset.
Statistical analysis for 16S rRNA community sequen-
cing was done in QIIME2 and R (ver 3.6.1). Shannon,
Simpson, and Chao1 richness indices were computed at
the ASV level to measure alpha diversity. For every
group-visit combination, pairwise comparisons of inter-
ests (between visits in all three feeding groups and be-
tween groups at visits 1 and 3) were made using
Kruskal-Wallis tests. FDR correction was incorporated
for all statistical test and significance was determined
with a significance cutoff at 0.05. For beta diversity, the
vegan R package was used to compute Bray Curtis dis-
similarity matrix which was further analyzed with a per-
mutational multivariate analysis of variance (PERM
ANOVA) test. Principal Coordinates Analysis (PCoA)
plots were drawn based on Bray Curtis distance matrix.
Comparisons of community composition were con-
ducted at the ASV level.
To identify significant differences in taxonomic com-
position between visits or feeding groups, features with
very low counts and those that are unlikely to be signifi-
cant in comparison analyses were filtered out and ex-
cluded. This includes removal of features that were
singletons and were only detected in a single sample.
Additionally, features with variances that were among
the lowest 10% were also removed to improve accuracy
of comparative analyses. After subsequent filtering, 249
features which were composed of 72 genera, were used
for subsequent analyses. Raw values of relative abun-
dances are located in Additional File 2: Table S3. To as-
sess taxonomic differences between groups and/or visits,
multiple approaches were used. Analyses in R included
Wilcoxon tests of taxonomic abundance, DESeq2 [95]
and random forest classification.
Log2-fold change of median proportions were calcu-
lated, and significant testing was carried out. Pairwise Wil-
coxon signed rank test with FDR correction was used to
identify significantly different genera between visits for
each feeding group and pairwise Wilcoxon rank sum test
with FDR correction was used to compare genera between
feeding groups at day 60. Metacoder [96] was used to gen-
erate heatmap trees. For visualization purposes, features
that appeared in less than three samples or had fewer than
10 reads per sample and were not statistically significant
were excluded from the heat trees (although still consid-
ered during significance testing). A reference tree was gen-
erated for the heatmap trees.
The random Forest package in R was used to carry out
a random forest classification analysis to identify top
predictors (genera) that discriminate between baseline
and day 60 for each feeding group. DESeq2 was used to
compare and identify specific ASVs that were signifi-
cantly different between baseline and day 60 for each
feeding group. ASVs with an FDR < 0.05 were consid-
ered significant. Shrinkage estimations of log2 fold
change values were computed. A high positive fold-
change does not necessarily reflect high abundance and
should be interpreted as an increase in a specific ASV
from baseline to Day 60.
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variants present in infant fecal samples throughout all treatment and
timepoints. Table S4. Relative abundances of amplicon sequence
variants present in individual infant fecal samples. Each column
represents an indivdual fecal sample within a particular treatment and
timepoint.
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